Tag: Covaxin Latest News

COVAXIN Latest Peer Review Shows robust safety, immunogenicity in 2-18 years Old

COVAXIN is Safe, Highly Immunogenic in 2-18 Years Old – The Lancet Review

Bharat Biotech today announced COVAXIN Latest Peer Review published in the Lancet Infectious Disease Journal . The company…

By